Add to Favorites Newsroom RSS Share
fb-shareRutgers Cancer Institute of New Jersey
New Brunswick, NJ USA

Our News on Newswise

screenNJPressRelease500px.jpg

Expanded Practice and Policy Recommendations made by Collaborative Program to Improve Prevention of Prevalent Cancers

ScreenNJ, a collaborative program led by Rutgers Cancer Institute and funded in part by the New Jersey Department of Health, aims to increase prevention efforts for prevalent cancers thanks to recommendations resulting from a statewide gathering of...
8-Apr-2019 8:00 AM EDT Add to Favorites

JanetLibraryWeekMainReleasePHOTO.JPG

Medical Libraries: A Resource in the Cancer Journey

A cancer diagnosis can have an emotional as well as physical impact on patients, including coping with an uncertain prognosis, making treatment decisions, and learning how to manage treatment effects. A medical library at New Jersey's only...
8-Apr-2019 8:00 AM EDT Add to Favorites

ResearchTubesReleasePhoto.jpg

Targeting Opioid Receptors to Reduce Breast Cancer Development and Spread

In the search for more effective therapies for breast cancer, researchers from Rutgers Cancer Institute of New Jersey and Rutgers University are targeting opioid receptors to potentially reduce the development and spread of certain breast cancer...
1-Apr-2019 4:05 PM EDT Add to Favorites

Brain Release Photo.jpg

Examining a Small Molecule Inhibitor in the Treatment of Aggressive Brain Tumor Type

Fast growing brain tumors known as glioblastoma multiforme often present treatment challenges due to their diverse tumor cell types and their ability to spread into healthy brain tissue. A Rutgers Cancer Institute of New Jersey researcher examines...
2-Apr-2019 7:05 AM EDT Add to Favorites

MehnertPressReleasePhotoMon.JPG

Exploring Immunotherapy in Small Cell Lung Cancer

Phase 1b and phase 2 clinical trials examining pembrolizumab for advanced small cell lung cancer who received two or more lines of prior treatment show anti-tumor activity with durable responses and manageable toxicity. Rutgers Cancer Institute of...
1-Apr-2019 8:30 AM EDT Add to Favorites

MelanomaSunscreenRelease.jpg

Examining a Web-Based Behavioral Intervention to Promote Sun Protection and Skin Self-Exams in Melanoma Patients

Researchers at Rutgers Cancer Institute of New Jersey and University of Virginia Center for Behavioral Health and Technology have found that a web-based intervention targeting sun protection behaviors and skin self-examinations in melanoma patients...
7-Mar-2019 11:45 AM EST Add to Favorites

CARTRelease.jpg

CAR-T Cell Therapy Available at Rutgers Cancer Institute of New Jersey and Robert Wood Johnson University Hospital

Those with B-cell lymphomas that do not respond to standard therapies now have another treatment option in New Jersey, as CAR-T cell therapy is now being offered at Robert Wood Johnson University Hospital New Brunswick, an RWJBarnabas Health...
4-Mar-2019 8:00 AM EST Add to Favorites

surgery2shutterstock_375659647sm.jpg

Lymph Node Removal Procedure as First-Line Treatment for Testicular Seminoma Associated with Favorable Survival Rates

Investigators at Rutgers Cancer Institute of New Jersey have found that a surgical procedure, when used as a first-line therapy for a form of testicular cancer known as seminoma, is associated with favorable survival rates.
12-Feb-2019 11:05 AM EST Add to Favorites


see all news

Our Experts on Newswise

screening50scouplewdocrelease.jpg

Colorectal Cancer: Advancing Awareness

Colorectal cancer is the third leading cancer in both new cases and cancer deaths in the United States. While colorectal cancer incidence declined 3.7 percent annually from 2006 to 2015 for those 55 and older, rates have increased 1.8 percent...
18-Mar-2019 3:05 PM EDT

lungartredshutterstock_5325632082.jpg

A New Tool to Help Fight an Old Enemy – Lung Cancer

In the U.S., lung cancer remains the leading cause of cancer death among both men and women. The primary reason for high death rates for lung cancer is the fact that this disease is typically detected in very late stages. A Rutgers University expert...
30-Oct-2018 5:05 PM EDT

sicklecell18card-1-L.jpg

September is Sickle Cell Disease Awareness Month

Sickle cell disease is a common inherited blood disorder, affecting an estimated 100,000 Americans of different racial and ethnic groups. A Rutgers Cancer Institute of New Jersey expert shares more about the importance of early diagnosis and...
24-Sep-2018 8:00 AM EDT

thyroidpuzzleshutterstock_342277517.jpg

Thyroid Cancer 101

While thyroid cancers are common, they may not be as widely understood as other common cancers such as breast or prostate. A Rutgers Cancer Institute of New Jersey expert shares more about the butterfly-shaped gland in the lower neck and how...
18-Sep-2018 8:00 AM EDT

womenmulticulturalshutterstock_583329955.jpg

Ovarian Cancer: What You Need to Know

During this Gynecologic Cancers Awareness Month, a Rutgers Cancer Institute of New Jersey expert shares info on symptoms and treatment of ovarian cancer.
14-Sep-2018 12:00 PM EDT

PCmenwhiteshutterstock_78224503.jpg

Prostate Cancer PSA Screening: Finding Clarity in Confusion

With recent changes in recommendations for PSA testing for prostate cancer, confusion may exist for those considering the screening. A Rutgers Cancer Institute of New Jersey expert shares what one needs to know when discussing the topic with his...
13-Sep-2018 8:05 AM EDT

palliativecareshutterstock_555960769lg.jpg

Palliative Care: Another Level of Support in the Cancer Journey

With word this week that former PGA Tour golfer Jarrod Lyle is transitioning from treatment for acute myeloid leukemia to palliative care, one might wonder what that form of care entails. A Rutgers Cancer Institute of New Jersey expert shares more...
1-Aug-2018 7:05 AM EDT

fathersdayblog_image.jpg

Checking in (and Checking up) on Dad this Father’s Day

Instead of another tie or tools, give the gift of good health this Father’s Day. As Rutgers Cancer Institute of New Jersey experts note, it’s as simple as encouraging regular health screenings to protect against cancer.
14-Jun-2018 4:05 PM EDT

see all experts

Our YouTube Videos

About

As New Jersey’s only National Cancer Institute-designated Comprehensive Cancer Center, Rutgers Cancer Institute of New Jersey is dedicated to improving the prevention, detection, treatment, and care of patients with cancer, through the transformation of laboratory discoveries into clinical practice. Rutgers Cancer Institute of New Jersey delivers advanced comprehensive care to adults and children including access to clinical trials and conducts cutting-edge cancer research.

The coveted NCI designation, awarded to only 47 such centers nationwide, is granted competitively to institutions characterized by scientific excellence and the ability to bring research discoveries to patients. To gain a "comprehensive" designation, the highest ranking given by the NCI, a center must meet rigorous criteria in cancer care, research, prevention and education.

The leadership of Rutgers Cancer Institute is comprised of distinguished researchers and physicians who are internationally recognized in their field. Basic scientists, clinical researchers, and population scientists meet regularly to exchange information and ensure that laboratory discoveries are refined and applied to clinical care as quickly as possible, that clinical observations reach laboratory researchers on a continuing basis, and that prevention strategies are interwoven in to all research programs.

Experts

No experts available.

Contacts

Main Box
Program Assistant

@cinj.rutgers.edu

732-235-7940

Sue Caputo
Program Assistant

scaputo@cinj.rutgers.edu

732-235-7940

Michele Fisher
Public Relations Manager

michele.fisher@rutgers.edu

732-235-9872

Twitter twitter-icon

Chat now!